The Boston Foundation’s Business Equity Investment Fund and CEI Ventures Back Category-Defining AI Platform Transforming MedTech Quality, Regulatory, and Product Development

BOSTON--(BUSINESS WIRE)--

Quality Means Business (QMB), an emerging leader in AI-driven MedTech SaaS, has closed a $2 million seed round to launch QualiVerse®, a Regulatory Intelligence Engine that helps medical device innovators achieve compliance, accelerate new product development, and scale safely to market. The round, led by The Boston Foundation’s Business Equity Investment Fund and CEI Ventures, positions QMB as a category-defining company at the intersection of AI, regulatory intelligence, and MedTech innovation.

“QMB is building the category infrastructure that MedTech has been missing. Michel's vision is deeply informed by lived experience as both a regulator and SaaS product architect — and this is exactly the kind of entrepreneur we back to redefine industries.” — Anthony Rust, Fund Manager of the Business Equity Investment Fund

“We’re excited to support QMB in bringing critical innovation to the MedTech sector. QualiVerse® represents the type of transformative technology that not only drives business growth but also has the potential to improve patient outcomes on a global scale. This aligns perfectly with our mission to invest in companies that create meaningful economic opportunity while advancing social impact.” — Orlando Watkins, Vice President and Chief Program Officer of The Boston Foundation

“CEI Ventures is proud to partner with QMB. We're especially proud that all current and planned jobs at QMB exceed the MIT Living Wage for Norfolk County, aligning with CEI Ventures’ Good Jobs Framework and our commitment to equitable, high-quality employment. QualiVerse® is the rare platform that marries technical sophistication with impact at scale — accelerating safer devices to patients worldwide.” — Shannon Bean, Principal, CEI Ventures

“Quality and regulatory are the unsung heroes of medical innovation — they safeguard lives while too often operating in the shadows. With QualiVerse®, we're giving these teams the intelligent platform they deserve — a system that makes compliance not a bottleneck, but a catalyst for innovation. As both a MedTech regulatory veteran and product leader in enterprise SaaS, I know firsthand the cost of delay and the urgency of getting this right.” — Michel Moravia, Chairman & CEO of QMB

Building on early enterprise traction and pilot interest from leading device innovators, QMB will use the funding to expand engineering, deepen data integrations, and advance RegTech-as-Infrastructure™ pilots with MedTech manufacturers in late 2025.

Strategic Governance

Michel Moravia, Chairman & CEO – 15+ years in MedTech regulatory and quality

Orlando Watkins, Board Director – The Boston Foundation

Robert Bennett, Board Director – Scaled EngageSmart® to PE acquisition

Shannon Bean, Board Observer – CEI Ventures

About QualiVerse®

QualiVerse® is an AI-native enterprise platform unifying design control, risk management, regulatory intelligence, and compliance scoring. It transforms standards such as ISO 13485, ISO 14971, IEC 62304, and EU MDR into a workflow-aware operating system that drives faster product launches, lower compliance risk, and measurable ROI across quality and regulatory functions.

About The Boston Foundation

Founded in 1915, The Boston Foundation is among the nation’s largest and oldest community foundations, managing $1.9 billion in assets. It partners with nearly 1,000 donors to build a prosperous, equitable Greater Boston region where justice and opportunity are extended to all. Learn more at www.tbf.org.

About CEI Ventures

CEI Ventures, Inc. is a leading impact venture capital firm founded in 1994, investing in companies driving social and environmental impact. Based in Maine, CEI Ventures is wholly owned by Coastal Enterprises, Inc. (CEI), a CDFI that has deployed more than $1.6 billion to grow businesses and strengthen communities. Learn more at www.ceimaine.org/cei-ventures.

About Quality Means Business (QMB)

Quality Means Business, Inc. (QMB) builds QualiVerse®, the Regulatory Intelligence Engine for MedTech quality, regulatory, and NPD. Through AI copilots, predictive analytics, and compliance-aware automation, QMB enables innovators to launch safer, more effective devices — faster and with confidence. Follow Michel Moravia on LinkedIn for founder insights and updates from Quality in the Boardroom, QMB’s podcast spotlighting leaders shaping the future of medical innovation. Learn more at QMB.ai and QualiVerse.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251112838343/en/

Source: QMB Inc.